Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1994-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0091-3057(94)90172-4PMID 8208787
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)

  2004cited by this paper
• Drug discrimination studies with MDMA and amphetamine

  2004cited by this paper
• Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

  2004cited by this paper
• Relationships of psychotomimetic to anti-serotonin potencies of congeners of lysergic acid diethylamide (LSD-25)

  2004cited by this paper
• Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors

  1992cited by this paper
• Stereoselective LSD-like activity in d-lysergic acid amides of (R)- and (S)-2-aminobutane.

  1992cited by this paper
• (+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in studies of 3,4-methylenedioxy-methamphetamine-like behavioral activity.

  1990cited by this paper
• [125I]-2-(2,5-dimethoxy-4-iodophenyl)aminoethane ([125I]-2C-I) as a label for the 5-HT2 receptor in rat frontal cortex.

  1990cited by this paper
• Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.

  1990cited by this paper
• Biochemistry and physiology of substance abuse

  1989cited by this paper
• Facilitation of 8-OHDPAT-induced forepaw treading of rats by the 5-HT2 agonist DOI.

  1989cited by this paper
• Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.

  1989cited by this paper
• More about the misuse of Scatchard plots in binding studies.

  1988cited by this paper
• The hybridization state of nitrogen as a conformational variable in biologically active molecules

  1988cited by this paper
• Binding to the serotonin 5-HT2 receptor by the enantiomers of 125I-DOI.

  1987cited by this paper
• Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.

  1985cited by this paper
• Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

  1985cited by this paper
• Discriminative stimulus properties of lysergic acid diethylamide in the monkey.

  1985cited by this paper
• Analysis of radioligand binding experiments. A collection of computer programs for the IBM PC.

  1985cited by this paper
• Conformational analysis of the ergot alkaloids ergotamine and ergotaminine.

  1982cited by this paper
• A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

  1982cited by this paper
• Ca2+‐Guanine Nucleotide Interactions in Brain Membranes. II. Characteristics of [3H]Guanosine Triphosphate and [3H]β, γ‐Imidoguanosine 5′‐Triphosphate Binding and Catabolism in the Rat Hippocampus and Striatum

  1982cited by this paper
• Burger's Medicinal chemistry

  1980cited by this paper
• Recognition and activation mechanisms on the LSD/serotonin receptor: the molecular basis of structure activity relationships.

  1978cited by this paper
• LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.

  1978cited by this paper
• Conformational analysis. 130. MM2. A hydrocarbon force field utilizing V1 and V2 torsional terms

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Structural correlation between apomorphine and LSD: involvement of dopamine as well as serotonin in the actions of hallucinogens.

  1976cited by this paper
• Molecular structures of hallucinogenic substances: lysergic acid diethylamide, psilocybin, and 2,4,5-trimethoxyamphetamine.

  1973cited by this paper
• Molecular Structure of LSD

  1972cited by this paper
• A Conformational Study of Lysergic Acid and iso-Lysergic Acid Dialkylamides by Proton Magnetic Resonance Spectroscopy

  1972influential reference
• On the conformations of hallucinogenic molecules and their correlation.

  1969cited by this paper
• Lysergic Acid Diethylamide (LSD-25): XXIX. The Response Index as a Measure of Threshold Activity of Psychotropic Drugs in Man

  1959cited by this paper
• Studies on the pharmacology of D-lysergic acid cycloalkylamides.

  1958cited by this paper
• Comparative study on the serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids.

  1958cited by this paper
• PHARMACOLOGY OF LYSERGIC ACID DIETHYLAMIDE AND SOME OF ITS RELATED COMPOUNDS

  1957cited by this paper
• Pharmacology of d-lysergic acid morpholide (LSM).

  1957cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Analytical and behavioral characterization of N-ethyl-N-isopropyllysergamide (EIPLA), an isomer of N6 -ethylnorlysergic acid N,N-diethylamide (ETH-LAD).

  2023influential citation
• Structural analysis of an lysergic acid diethylamide (LSD) analogue N-methyl-N-isopropyllysergamide (MiPLA): Insights from Rotamers in NMR spectra.

  2023cites this paper
• Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders

  2022cites this paper
• [Identification of LSD Derivatives, 1cP-LSD, MIPLA and 1B-LSD in Illegal Products as Paper Sheet].

  2020cites this paper
• Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

  2020cites this paper
• In vitro metabolic fate of nine LSD-based new psychoactive substances and their analytical detectability in different urinary screening procedures

  2019cites this paper
• Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA)

  2018cites this paper
• Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD).

  2016cites this paper
• Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.

  2011influential citation
• Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action.

  2007cites this paper
• Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).

  2002cites this paper
• Quasi‐atomistic Receptor Surrogates for the 5‐HT2A Receptor: A 3D‐QSAR Study on Hallucinogenic Substances

  1999cites this paper
• Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.

  1998cites this paper
• Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists

  1995cites this paper
• LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors

  1995cites this paper
• Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.

  1995cites this paper